Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Lisata Therapeutics (LSTA) over the last 13 years, with Q3 2025 value amounting to $23000.0.

  • Lisata Therapeutics' Other Non-Current Assets fell 8855.72% to $23000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $23000.0, marking a year-over-year decrease of 8855.72%. This contributed to the annual value of $160000.0 for FY2024, which is 5180.72% down from last year.
  • Per Lisata Therapeutics' latest filing, its Other Non-Current Assets stood at $23000.0 for Q3 2025, which was down 8855.72% from $70000.0 recorded in Q2 2025.
  • Over the past 5 years, Lisata Therapeutics' Other Non-Current Assets peaked at $449000.0 during Q1 2023, and registered a low of $23000.0 during Q3 2025.
  • For the 3-year period, Lisata Therapeutics' Other Non-Current Assets averaged around $242545.5, with its median value being $246000.0 (2024).
  • As far as peak fluctuations go, Lisata Therapeutics' Other Non-Current Assets plummeted by 3541.2% in 2024, and later tumbled by 8855.72% in 2025.
  • Over the past 3 years, Lisata Therapeutics' Other Non-Current Assets (Quarter) stood at $332000.0 in 2023, then tumbled by 51.81% to $160000.0 in 2024, then crashed by 85.62% to $23000.0 in 2025.
  • Its Other Non-Current Assets stands at $23000.0 for Q3 2025, versus $70000.0 for Q2 2025 and $116000.0 for Q1 2025.